why is tirzepatide not working Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review Why Am I Not Losing
Description
Another GLP-1-focused digital service reported that app engagement (weight logging, feature use, coaching) significantly increased the odds of hitting meaningful weight-loss thresholds (525%) and reduced weight regain compared to non-engagement
Note: This analysis demonstrates that semaglutide occupies a unique position
The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: an anti-atherosclerotic action
WeightIt: Weighting for Covariate Balance in Observational Studies
